Bioprocess Automation Software Market Report 2026

Bioprocess Automation Software Market Overview

• Bioprocess Automation Software market size has reached to $3.07 billion in 2025 • Expected to grow to $5.45 billion in 2030 at a compound annual growth rate (CAGR) of 12.2% • Growth Driver: Surge In Demand For Real-time Monitoring Fueling The Growth Of The Market Due To Efficiency, Quality, And Compliance Optimization • Market Trend: Strategic Partnerships Enhance Integrated Bioprocess Automation And Digital Workflow Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bioprocess Automation Software Market?

Bioprocess automation software refers to specialized computer programs designed to monitor, control, and optimize biological production processes. It enables real-time data collection, process analysis, and automated adjustments to maintain optimal conditions, improve consistency, and enhance efficiency. Bioprocess automation software helps streamline operations, reduce human error, and accelerate the development of biopharmaceutical products. The main components of bioprocess automation software include software and services. Software refers to platforms and tools that automate bioprocess workflows, ensuring efficiency, accuracy, and regulatory compliance. The solutions are deployed on-premise, cloud-based, or in hybrid models and serve enterprises of all sizes, including small and medium enterprises and large enterprises. The key applications of upstream processing, downstream processing, quality control, manufacturing operations, data management, and other applications, while the end-users include pharmaceutical companies, research institutes, contract manufacturing organizations, and other end-users.

What Is The Bioprocess Automation Software Market Growth Forecast?

The bioprocess automation software market size is expected to see rapid growth in the next few years. It will grow to $5.45 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to growing deployment of AI-driven process optimization, increasing integration with cloud-based data management, rising demand for predictive bioprocess monitoring, expansion of hybrid automation solutions, growing focus on reducing human error and operational costs. Major trends in the forecast period include increasing adoption of cloud-based bioprocess automation software, rising demand for real-time data analytics in bioprocessing, growing integration with IoT-enabled bioreactors, expansion of quality and regulatory compliance automation, rising focus on upstream and downstream process optimization.

Global Bioprocess Automation Software Market Segmentation

1) By Component: Software, Services 2) By Deployment Type: On Premise, Cloud Based, Hybrid 3) By Enterprise Size: Small And Medium Enterprises, Large Enterprises 4) By Application: Upstream Processing, Downstream Processing, Quality Control, Manufacturing Operations, Data Management, Other Applications 5) By End User: Pharmaceutical Companies, Research Institutes, Contract Manufacturing Organizations, Other End-Users Subsegments: 1) By Software: Process Automation Software, Data Management Software, Quality Management Software, Regulatory Compliance Software, Analytics And Reporting Software 2) By Services: Implementation Services, Consulting Services, Maintenance And Support Services, Training Services, Managed Services

What Is The Driver Of The Bioprocess Automation Software Market?

The growing investment in research and development is expected to propel the growth of the bioprocess automation software market going forward. Research and development refers to systematic activities undertaken by businesses and institutions to create new knowledge, improve existing products, or develop innovative technologies and processes. The rise in R&D investment is largely driven by increasing demand for biologics and advanced therapeutics, as pharmaceutical and biotechnology companies allocate substantial resources to develop complex biopharmaceutical products that require sophisticated manufacturing processes. Growing R&D investment fuels demand for bioprocess automation software by requiring advanced digital systems to manage increasingly complex biomanufacturing workflows, ensure regulatory compliance, and optimize production efficiency across research and commercial operations. For instance, in February 2025, according to the National Center for Science and Engineering Statistics (NCSES), a US-based government statistical agency, U.S. research and development expenditures rose from $892 billion in 2022 to $940 billion in 2023, reflecting an increase of $48 billion. Therefore, growing investment in research and development is driving the growth of the bioprocess automation software industry.

Key Players In The Global Bioprocess Automation Software Market

Major companies operating in the bioprocess automation software market are Honeywell International Inc., Danaher Corporation, Siemens Healthineers AG, Parker Hannifin Corporation, Rockwell Automation Inc., Yokogawa Electric Corporation, Getinge AB, Waters Corporation, Bioengineering AG, Eppendorf SE, Tecan Group Ltd., Repligen Corporation, Hamilton Company, Pierre Guerin SAS, Inscripta Inc., INFORS HT AG, Automated Control Concepts Inc., Synthace Ltd., Flownamics Inc., ILS Automation Inc., and PendoTECH Inc.

Global Bioprocess Automation Software Market Trends and Insights

Major companies operating in the bioprocess automation software market are focusing on adopting strategic collaborations to deliver integrated digital solutions that improve process control, data connectivity, and manufacturing efficiency. Strategic collaborations are structured alliances where organizations work together to pursue common objectives by combining their expertise and capabilities that help businesses drive innovation, enter new markets, share risks, and strengthen their competitive position without undergoing a merger. For instance, in June 2024, AGU, a Germany-based provider of bioprocess automation technologies, partnered with Genedata, a Switzerland-based bioinformatics software company, to integrate AGU’s SmrtLine Data Cockpit middleware with the Genedata Biopharma Platform, creating a unified bioprocess automation solution that automates instrument data capture, streamlines data flow in GxP-regulated environments, and aims to improve efficiency and data integrity for biopharma process development.

What Are Latest Mergers And Acquisitions In The Bioprocess Automation Software Market?

In August 2024, Danaher Corporation, a US-based healthcare company, acquired Genedata AG for an undisclosed amount. Through this acquisition, Danaher Corporation strengthens its life sciences portfolio by integrating Genedata’s bioprocess automation software to streamline, digitalize, and optimize biopharmaceutical research, development, and manufacturing workflows. Genedata AG is a Switzerland-based company that provides bioprocess automation software through its Genedata Bioprocess platform.

Regional Insights

North America was the largest region in the bioprocess automation software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bioprocess Automation Software Market?

The bioprocess automation software market consists of revenues earned by entities by providing services such as system integration services, real-time process monitoring and control, data analytics and visualization services, regulatory compliance, and electronic batch record (EBR) management services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Bioprocess Automation Software Market Report 2026?

The bioprocess automation software market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess automation software industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.